U.S. markets closed

Siemens Healthineers AG (SMMNY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
22.64+0.02 (+0.09%)
At close: 3:54PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close22.62
Open22.54
Bid0.00 x 0
Ask0.00 x 0
Day's Range22.47 - 22.64
52 Week Range16.19 - 26.88
Volume35,459
Avg. Volume81,791
Market Cap45.085B
Beta (5Y Monthly)0.51
PE Ratio (TTM)30.84
EPS (TTM)0.73
Earnings DateN/A
Forward Dividend & Yield0.43 (1.91%)
Ex-Dividend DateFeb 13, 2020
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Varian Stockholders Approve Combination with Siemens Healthineers
    PR Newswire

    Varian Stockholders Approve Combination with Siemens Healthineers

    Varian (NYSE: VAR) today announced that its stockholders have voted to approve the previously announced pending combination with Siemens Healthineers AG (Frankfurt: SHL) at a special meeting. Varian stockholders voted overwhelmingly in favor of the transaction.

  • Joe Kaeser's Retirement Gift at Siemens: A Rusty Mercedes?
    Bloomberg

    Joe Kaeser's Retirement Gift at Siemens: A Rusty Mercedes?

    (Bloomberg Opinion) -- By spinning off its energy generation business this week, Siemens AG took another step toward unwinding its unwieldy conglomerate structure.Not far up the autobahn in Stuttgart there’s another German industrial conglomerate that could do with the same medicine: Daimler AG, owner of Mercedes-Benz and the world’s biggest truck maker. Happily, the architect of the Siemens reinvention, Chief Executive Officer Joe Kaeser, might be available to help.  Listing Siemens Energy AG is one of Kaeser’s last big strategic moves at the helm of the factory automation giant. He’s due to hand over some responsibilities to successor Roland Busch later this week before stepping down in February. He already has a new gig lined up as chairman of Siemens Energy’s supervisory board. But that won’t occupy all his time.The chairmanship of Daimler has just become free, too, and it’s a job where Kaeser’s capital markets prowess and willingness to shake up Germany’s corporate culture could prove useful.Daimler started looking for a new chairman after its ex-CEO Dieter Zetsche withdrew his candidacy at the weekend. The incumbent Manfred Bischoff retires next year. Zetsche’s once stellar reputation has soured lately because of legal troubles related to Mercedes’s diesel emissions and the perception that it was too slow to invest in electric vehicles.Kaeser has been a non-executive director at Daimler for years, so he must know that it suffers from the same disease he’s tried to cure at Siemens. Daimler’s market value is less than 50 billion euros ($58 billion). That’s pretty lamentable considering it generated 173 billion euros in revenue last year and has some of the most desirable automotive brands. The stock is where it was a decade ago. Based on an analysis of similar businesses such as Volvo AB, Daimler’s commercial vehicles unit alone is worth 35 billion euros, according to Bernstein Research analyst Arndt Ellinghorst. Famously bureaucratic, Daimler has already taken steps to help investors better appreciate the value of its businesses. Mercedes’s car-sharing and taxi-hailing units were merged with those of rival BMW AG. There was speculation that the combined entity — called Your Now — might one day be listed. The ride-hailing part has since drawn takeover interest from Uber Technologies Inc., Bloomberg News reported.Daimler also spent several hundred million euros to legally separate its cars and vans business from its trucks and bus activities. But its executives haven’t hurried to take the next logical step: an initial public offering of the commercial-vehicle assets.In fairness, Germany’s two-tier boards give workers a big say in how companies are run, and achieving consensus often rules out radical measures. Kaeser’s ability to overcome such inertia was the one remarkable thing about his seven-year tenure at Siemens. He really shook things up.Kaeser merged Siemens’s wind turbine business with Spain’s Gamesa and sold shares in Siemens Healthineers AG, which supplies hospital equipment. By giving these businesses their own stock market listings and independence, Kaeser kept activist investors at bay. Siemens shares have returned almost 9% annually since Kaeser took over in 2013, according to Bloomberg data, which is better than its industrial peer group.He’s had failures, too. In 2014 Kaeser overpaid for Dresser Rand, a U.S. oil and gas equipment supplier. A train merger with Alstom SA was blocked by antitrust concerns and Siemens Gamesa Renewable Energy SA has struggled with management upheaval. Siemens stock still trades at a discount to industrial-automation rivals such as Rockwell Automation Inc.Kaeser’s appointment might also unnerve Stuttgart for non-corporate reasons too. He’s been increasingly outspoken on political and social issues. The 78-year old Bischoff isn’t on Twitter.Perhaps some spark would do Daimler good, though. New CEO Ola Kallenius is the first non-German to run the car giant and, after a shaky start, he seems determined to address Mercedes’s chronic underperformance. A big restructuring lies ahead.Provided Kaeser didn’t overshadow the younger CEO, the Siemens boss might bring some useful tools for renewing Daimler.This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Chris Bryant is a Bloomberg Opinion columnist covering industrial companies. He previously worked for the Financial Times.For more articles like this, please visit us at bloomberg.com/opinionSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

  • Siemens Healthineers Announces Collaboration Agreement for Assay Development With an Initial Focus on Multiple Sclerosis
    Business Wire

    Siemens Healthineers Announces Collaboration Agreement for Assay Development With an Initial Focus on Multiple Sclerosis

    Siemens Healthineers announced today a master collaboration agreement with Novartis Pharma AG to design, develop, and commercialize diagnostic tests for therapeutic products across Novartis’ therapeutic pipeline. The initial program assists the development of a serum NfL immunoassay to support Novartis’ MS and other neuroscience programs.